1. Home
  2. WVE vs CBL Comparison

WVE vs CBL Comparison

Compare WVE & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$16.01

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo CBL & Associates Properties Inc.

CBL

CBL & Associates Properties Inc.

HOLD

Current Price

$37.08

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
CBL
Founded
2012
1978
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2015
1993

Fundamental Metrics

Financial Performance
Metric
WVE
CBL
Price
$16.01
$37.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
1
Target Price
$27.53
$45.00
AVG Volume (30 Days)
12.9M
157.9K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
4.85%
EPS Growth
N/A
297.30
EPS
N/A
4.02
Revenue
$109,230,000.00
$553,643,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$31.09
N/A
P/E Ratio
N/A
$9.23
Revenue Growth
103.75
5.74
52 Week Low
$5.28
$21.10
52 Week High
$21.73
$37.39

Technical Indicators

Market Signals
Indicator
WVE
CBL
Relative Strength Index (RSI) 65.75 78.88
Support Level $6.93 $34.89
Resistance Level $21.73 $35.80
Average True Range (ATR) 1.51 0.68
MACD 1.14 0.25
Stochastic Oscillator 61.45 94.46

Price Performance

Historical Comparison
WVE
CBL

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CBL CBL & Associates Properties Inc.

CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.

Share on Social Networks: